US Broker Ratings

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: A Biotech Powerhouse with a 72.71% Upside Potential

CytomX Therapeutics, Inc. (NASDAQ: CTMX) has emerged as a compelling player in the biotechnology sector, offering intriguing opportunities for investors keen on the healthcare space. As a biopharmaceutical company focused..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Promising Upside Potential with a 38.47% Target

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a San Diego-based biotechnology firm, is capturing investor attention with its promising growth potential in the healthcare sector. Specializing in targeted therapies for serious diseases,..

Arcturus Therapeutics Holdings (ARCT): An Investor’s Insight into a Potential 236% Upside

Arcturus Therapeutics Holdings Inc. (ARCT), a biotechnology company headquartered in San Diego, California, is making waves in the healthcare sector with its promising advancements in infectious disease vaccines and treatments..

Aura Biosciences (AURA) Stock Analysis: A Biotech Gem with 245% Upside Potential

Aura Biosciences, Inc. (NASDAQ: AURA) is making waves in the biotechnology sector with its innovative approach to treating solid tumors. As a clinical-stage biotech company based in Boston, Massachusetts, Aura..

Yalla Group Limited (YALA) Stock Analysis: Exploring a 25% Upside Potential in the Emerging MENA Social Networking Market

Yalla Group Limited (NYSE: YALA), a technology pioneer rooted in the United Arab Emirates, stands out as a promising investment in the burgeoning Middle East and North Africa (MENA) tech..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Unpacking the 46.94% Potential Upside

SANUWAVE Health, Inc. (SNWV), a promising player in the healthcare sector, particularly in the medical devices industry, is drawing attention with an impressive potential upside of 46.94%. Headquartered in Eden..

Neurogene Inc. (NGNE) Stock Analysis: Exploring a 193% Potential Upside in Biotechnology

In the fast-evolving landscape of biotechnology, Neurogene Inc. (NASDAQ: NGNE) presents a compelling opportunity for investors seeking exposure to the healthcare sector’s innovative edge. With a focus on developing genetic..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Potential 51% Upside Awaits Investors

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is making waves in the biotechnology sector with its innovative approach to tackling fibrosis-driven diseases. Based in Sugar Land, Texas, this clinical-stage biopharmaceutical company has..

Alumis Inc. (ALMS): Investor Outlook on a Biotech Stock with a 367% Upside Potential

Alumis Inc. (NASDAQ: ALMS) has emerged as a compelling player in the biotechnology sector, capturing investor attention with a staggering potential upside of 367.98%. This clinical-stage biopharmaceutical company, headquartered in..

Canopy Growth Corporation (CGC): Investor Outlook on a Volatile Cannabis Pioneer

Canopy Growth Corporation (NYSE: CGC), a prominent figure in the cannabis industry, has been a focal point for investors seeking exposure to the burgeoning legal cannabis market. With a market..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Navigating Biotech Opportunities with a 1.97% Potential Upside

iTeos Therapeutics, Inc. (NASDAQ: ITOS) stands at the forefront of the biotechnology sector, with a focus on developing immuno-oncology therapeutics that could revolutionize cancer treatment. Operating as a clinical-stage biopharmaceutical..

Cartesian Therapeutics, Inc. (RNAC): Analyst Ratings Signal Significant 255.75% Upside Potential

For investors keeping a keen eye on the biotechnology sector, Cartesian Therapeutics, Inc. (NASDAQ: RNAC) presents a fascinating opportunity. Specializing in the development of mRNA cell therapies for autoimmune diseases,..

Spok Holdings, Inc. (SPOK) Stock Analysis: Healthcare Communication Leader with a 26.81% Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK) stands as a significant player in the healthcare communication sector, offering a suite of solutions that streamline workflows for clinicians and enhance patient outcomes. With..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unveiling a Potential 126% Upside in Women’s Cancer Therapies

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), headquartered in San Francisco, is a clinical-stage biopharmaceutical company making significant strides in the healthcare sector, specifically within the biotechnology industry. With a market capitalization..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: A 38.69% Upside Potential Ignites Investor Interest

ClearPoint Neuro Inc. (NASDAQ: CLPT), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 38.69%, according to recent..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a Potential 52.98% Upside in the Genomics Market

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors intrigued by the genomics..

Absci Corporation (ABSI) Stock Analysis: A Biotech Gem with 159% Upside Potential

Absci Corporation (NASDAQ: ABSI), a pioneering force in the biotechnology sector, stands out with its compelling investment thesis. Operating at the intersection of artificial intelligence and drug discovery, Absci’s unique..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring a Potential 110% Upside Amidst Healthcare Innovation

Nano-X Imaging Ltd (NASDAQ: NNOX) is carving its niche in the healthcare sector with its innovative medical devices, particularly in the realm of digital imaging. As a company based in..

Mereo BioPharma Group plc (MREO) Stock Analysis: Unveiling a 247% Potential Upside in Biotech

Mereo BioPharma Group plc (NASDAQ: MREO), a UK-based biopharmaceutical company, has captured the attention of investors with its promising pipeline and substantial potential upside. Specializing in the development and commercialization..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 42% Potential Upside in the Medical Devices Sector

Varex Imaging Corporation (VREX), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of 42.27%. The company, headquartered in Salt Lake City, Utah,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds